- FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms.
FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms.
Biomedicine and Pharmacotherapy (2023)
Ahmed, et al.
PMID37068330
MATERIALS
Product Number
Brand
Product Description